prednisolone has been researched along with Benign Optic Nerve Neoplasm in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Jamal, RT | 1 |
| Kivelä, T | 1 |
1 other study available for prednisolone and Benign Optic Nerve Neoplasm
| Article | Year |
|---|---|
Progressive visual loss and an optic disc tumour in a young man.
Topics: Administration, Oral; Adult; Diagnosis, Differential; Glucocorticoids; Humans; Injections, Intraveno | 2008 |